Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:21 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 669 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: University of Illinois Chicago Clear all

Conditions: Contraception
Interventions: IUD; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older · Female only
Enrollment: 404 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 4
States / cities: La Jolla, California • San Diego, California • Chicago, Illinois + 1 more

Conditions: Depression, Anxiety, PTSD, Family Dynamics, Social Functioning, Family Support, Family Relations
Interventions: CAFES2; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 12 Years to 55 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Alcohol Use Disorder
Interventions: CM-PST, CM only; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 24 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Opioid Use Disorder, Injection Drug Use, Skin and Soft Tissue Infections (SSTIs)
Interventions: Chlorhexidine gluconate, Isopropyl Alcohol 70% Topical Application Solution, Skin Prep Before Injecting Recreational/Street Drugs; Drug · Behavioral
Lead sponsor: Gabriel John Culbert; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cognitive Function Decline, Air Pollution Exposure, Respiratory Inflammation
Interventions: Clean Indoor Air Exposure (Control), Exposure to Cooking-Generated Ultrafine Particles and Gases; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Audio Processing Delay
Interventions: Audio delay; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Asthma
Interventions: ACTION Intervention, Education Control; Behavioral · Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 224 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer, Radiation Toxicity
Interventions: amifostine trihydrate, cisplatin, paclitaxel, radiation therapy; Drug · Radiation
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prostate Cancer (Diagnosis)
Interventions: The Stockholm3 test; Diagnostic Test
Lead sponsor: Karolinska Institutet; Other
Eligibility: 45 Years to 75 Years · Male only
Enrollment: 2,152 participants
Timeline: 2019 – 2023
U.S. locations: 13
States / cities: Los Angeles, California • Palo Alto, California • Chicago, Illinois + 4 more

Conditions: Opiod Use Disorder
Interventions: OUD screening, MOUD, Continuity of care; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 16 Years and older
Enrollment: 271,031 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Elevated Blood Pressure, Habitual Sleep Duration of Less Than or Equal to 7 Hours
Interventions: Sleep extension intervention, Health education; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Risperdal Consta (drug), Social Skills Training; Drug · Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 55 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 2
States / cities: Chicago, Illinois • White Plains, New York

Conditions: Obesity, Diabetes
Interventions: Time restricted feeding; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 65 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer
Interventions: Cyclophosphamide, Methotrexate, Capecitabine; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2034
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression, Anxiety, Transition
Interventions: Adapted Teens Achieving Mastery over Stress (TEAMS) Treatment, Adapted Teens Achieving Mastery over Stress (TEAMS) Prevention, Adapted Competent Adulthood Transition with Cognitive-behavioral & Interpersonal Training (CATCH-IT), Strengthening Families, Virtual psycho-educational discussion groups for caregivers and participants, Maternal Child Health Bureau (MCHB) Care Coordination; Behavioral · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 13 Years to 20 Years
Enrollment: 780 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gastric Adenocarcinoma, Gastric Cancer
Interventions: Neoadjuvant chemotherapy, Olanzapine; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Balance, Postural, Prevention, Accident
Interventions: treadmill slip perturbation, treadmill training placebo, observation training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 65 Years and older
Enrollment: 308 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hepatitis C, Hiv, Coinfection, HIV, Substance Use Disorders
Interventions: Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Decompensated Heart Failure
Interventions: Addition of oral Metolazone, Furosemide dose escalation; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: HIV Infections
Interventions: Project ICARE, HCT; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS) Primary Progressive, Multiple Sclerosis (MS) Secondary Progressive, Multiple Sclerosis Acute and Progressive
Interventions: Multicomponent balance intervention consisting of four components including dual-tasking, functional strength, vestibular and dynamic balance., Stretching; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 40 Years to 90 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Insomnia, COPD, Chronic Obstructive Pulmonary Disease, Fatigue
Interventions: Cognitive Behavioral Therapy for Insomnia, COPD Education, Attention Control; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 45 Years and older
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Coronary Artery Disease
Interventions: Regadenoson; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Healthy
Interventions: Telithromycin, azithromycin, bronchoalveolar lavage; Drug · Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 55 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Phoenix, Arizona

Search by objective public record fields.

Early vs. Interval Postpartum IUD Insertion

Hybrid Type 1 Randomized Pilot Trial of a Peer-led Family and Social Strengthening Group Intervention for Refugee Families

StuDy AimED at Increasing AlCohol AbsTinEnce

A Pilot Study to Evaluate Skin Swabbing With Chlorhexidine to Prevent Skin And Soft Tissue Infections Among People Who Inject Drugs

Short-Term Health Outcomes of Cooking UFP Exposure

Effects of Delay in Hearing Assistive Technology

Physical Activity Intervention for Black Women With Asthma

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Stockholm3 Validation Study in a Multi-Ethnic Cohort

Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System

Sleep Technology Intervention to Target Cardiometabolic Health

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

Time Restricted Feeding (4-hour Versus 6-hour) for Weight Loss in Obese Adults

BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer

BEhavioral Health Stratified Treatment (BEST) Study for Youth With Intellectual and/or Developmental Disabilities (IDD)

GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer

Effect of Adaptive Training for Balance Recovery

Zepatier in Patients with Substance Use

Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure

Project ICARE: Intervening for Community Awareness, Respect, & Empowerment

Home Based Functional Balance Intervention for Multiple Sclerosis

A Behavioral Therapy for Insomnia Co-existing With COPD

Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements

Intrapulmonary Pharmacokinetics of Antibiotics